IRINOTECAN AND TEMOZOLAMIDE AS EFFECTIVE SCHEDULE IN PROGRESSIVE AND THERAPY RESISTANT NEUROBLASTOMA - EXPERIENCE OF POLISH PEDIATRIC SOLID TUMORS GROUP

被引：0
|
作者：
Wieczorek, A. [1 ]
Stypinska, M. [2 ]
Hennig, M. [3 ]
Wieczorek, M. [4 ]
Januszkiewicz-Lewandowska, D. [5 ]
Zubowska, M. [6 ]
Peszynska-Bialczynska, K. [7 ]
Sobol-Milewska, G. [8 ]
Ussowicz, M. [9 ]
Balwierz, W. [1 ]
机构：
[1] Jagiellonian Univ, Coll Med, Polish Amer Inst Pediat, Krakow, Poland
[2] Childrens Mem Hlth Inst, Warsaw, Poland
[3] Med Univ Gdansk, Gdansk, Poland
[4] Chorzow Ctr Pediat & Oncol, Chorzow, Poland
[5] Med Univ, Poznan, Poland
[6] Med Univ, Lodz, Poland
[7] Nicolaus Copernicus Univ Torun, Coll Med Bydgoszcz, Bydgoszcz, Poland
[8] Med Univ Silesia, Upper Silesia Childrens Care Hlth Ctr, Katowice, Poland
[9] Med Univ, Wroclaw, Poland
来源：
PEDIATRIC BLOOD & CANCER | 2014年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-374
引用
收藏
页码：S337 / S337
页数：1
相关论文
共 26 条
  • [1] IRINOTECAN AND TEMOZOLAMIDE FOR CHILDREN WITH RELAPSED OR REFRACTORY RHABDOMYOSARCOMA, NEUROBLASTOMA AND EWING SARCOMA TUMORS: EXPERIENCE IN A SINGLE CENTER
    Gil, Gimena
    Cores, Maria
    Detoni, Deborah
    Puppa, Gabriela
    Garcia Lombardi, Merce
    Rey, Guad
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1093 - 1094
  • [2] Irinotecan and Temozolamide for Relapsed Solid Tumors: Mahak Paediatric Cancer Treatment and Research Center Experience
    Tashvighi, M.
    Mehrvar, A.
    Abbas, H. A. Amir
    Mohammad, F.
    Naderi, A.
    Anousha, N.
    Alebouyeh, M.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S263 - S263
  • [3] VINCRISTINE, IRINOTECAN AND TEMOZOLOMIDE TREATMENT FOR RECURRENT/PROGRESSIVE PEDIATRIC SOLID TUMORS
    Kebudi, R.
    Bay, S. Buyukkapu
    Cakir, F. B.
    Gorgun, O.
    Koc, B.
    Zulfikar, B.
    Agaoglu, F. Yaman
    Darendeliler, E.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S158 - S159
  • [4] Irinotecan for pediatric solid tumors: The Memorial Sloan-Kettering experience
    Cosetti, M
    Wexler, LH
    Calleja, E
    Trippett, T
    LaQuaglia, M
    Huvos, AG
    Gerald, W
    Healey, JH
    Meyers, PA
    Gorlick, R
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (02) : 101 - 105
  • [5] Pharmacokinetic and pharmacodynamic investigation of irinotecan hydrochloride in pediatric patients with recurrent or progressive solid tumors
    Kimura, T.
    Kashiwase, S.
    Makimoto, A.
    Kumagai, M.
    Taga, T.
    Ishida, Y.
    Ida, K.
    Nagatoshi, Y.
    Mugishima, H.
    Kaneko, M.
    Barrett, J. S.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2010, 48 (05) : 327 - 334
  • [6] Pediatric Testicular Tumors in Poland. A Report from the Polish Pediatric Solid Tumors Group (2008-2016)
    Stefanowicz, J.
    Jezierska, M.
    Adamkiewicz-Drozynska, E.
    Polczynska, K.
    Izycka-Swieszewska, E.
    Rapala, M.
    Bilska, K.
    Chelmecka-Wiktorczyk, L.
    Debski, R.
    Dembowska-Baginska, B.
    Karolczyk, G.
    Karpinska-Derda, I.
    Kazanowska, B.
    Leszczynska, E.
    Matysiak, M.
    Mizia-Malarz, A.
    Nurzynska-Flak, J.
    Sobol-Milejska, G.
    Peregud-Pogorzelski, J.
    Wachowiak-Szajdak, K.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S286 - S287
  • [7] Vincristine, irinotecan, and temozolomide treatment for refractory/relapsed pediatric solid tumors: A single center experience
    Bay, Sema Bueyukkapu
    Kebudi, Rejin
    Gorgun, Omer
    Zulfikar, Buelent
    Darendeliler, Emin
    Cakir, Fatma B.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (06) : 1343 - 1348
  • [8] Carboplatin is effective therapy for young children with progressive optic pathway tumors: A Pediatric Oncology Group phase II study
    Mahoney, DH
    Cohen, ME
    Friedman, HS
    Kepner, JL
    Gemer, L
    Langston, JW
    James, HE
    Duffner, PK
    Kun, LE
    NEURO-ONCOLOGY, 2000, 2 (04) : 213 - 220
  • [9] Topotecan in pediatric patients with recurrent and progressive solid tumors: A pediatric oncology group phase II study
    Nitschke, R
    Parkhurst, J
    Sullivan, J
    Harris, MB
    Bernstein, M
    Pratt, C
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1998, 20 (04) : 315 - 318
  • [10] LONG-TERM SURVIVAL OF PATIENTS WITH THERAPY RESISTANT NEUROBLASTOMA TREATED WITH IRINOTECAN/TEMODAL THERAPY. SINGLE CENTRE EXPERIENCE
    Wieczorek, Aleksandra
    Balwierz, Walentyna
    PEDIATRIC BLOOD & CANCER, 2010, 55 (05) : 887 - 888
123